FDA Brief

Warning letters Food

FDA warning letter to

CBD American Shaman, LLC

High riskIssued Nov 16, 2022Posted Nov 21, 2022Center for Food Safety and Applied Nutrition (CFSAN)

FDA warned CBD American Shaman that its CBD foods, sunscreen, and pet products are unsafe or unapproved drugs.

What happened

FDA reviewed the company's website in October 2022 and social media pages linked to it. FDA found CBD added to conventional human foods and animal foods, a CBD sunscreen labeled as a drug, and pet products promoted with drug claims. The letter says these products are adulterated (unsafe under the law) or unapproved and that some CBD foods are in forms attractive to children.

What FDA found

  1. CBD added to conventional human foods is an unsafe food additive, making those foods adulterated.

    FD&C Act sections 402(a)(2)(C)(i) and 409(a) [21 U.S.C. 342(a)(2)(C)(i), 348(a)]
  2. Adding CBD to food is a prohibited act because CBD is a drug approved under section 505 or subject to public clinical investigations, and FDA says no pre-drug food-marketing exception applies.

    FD&C Act section 301(ll) [21 U.S.C. 331(ll)]
  3. The CBD + Zinc Oxide Sunscreen is an unapproved new drug because it is not generally recognized as safe and effective and has no approved application.

    FD&C Act sections 505(a) and 301(d) [21 U.S.C. 355(a), 331(d)]
  4. The sunscreen is misbranded because it is a nonprescription drug subject to section 505G but does not comply, with CBD listed as an active ingredient not allowed by the sunscreen monograph.

    FD&C Act section 502(ee) [21 U.S.C. 352(ee)] and section 505G [21 U.S.C. 355h]
  5. The CBD pet products are unapproved new animal drugs and are unsafe because they lack an approved, conditionally approved, or index-listed animal drug application.

    FD&C Act sections 512(a) and 501(a)(5) [21 U.S.C. 360b(a), 351(a)(5)]
  6. Adding CBD to animal foods is a prohibited act under the same section 301(ll) drug-food prohibition.

    FD&C Act section 301(ll) [21 U.S.C. 331(ll)]

What FDA wants

FDA asks the company to correct the violations described in the letter. The provided letter excerpt does not state a response deadline.

Who should pay attention

  • retailers and online sellers of CBD foods and pet products
  • companies making CBD foods, drinks, or supplements
  • brands selling CBD sunscreens or pet chews with drug claims

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  2. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  3. House of Alchemy LLC dba CBD Dog Health Hamet & Love LLC dba MycoDog

    FDA warned CBD Dog Health and MycoDog their CBD and mushroom pet products are unapproved animal drugs, citing disease-treatment claims online.

    High risk
  4. Holista LLC dba HolistaPet

    FDA warned HolistaPet that its CBD animal products are unapproved new animal drugs and adulterated animal food.

    High risk